tiprankstipranks
Trending News
More News >
medmix AG (CH:MEDX)
:MEDX
Switzerland Market

medmix AG (MEDX) Ratios

Compare
0 Followers

medmix AG Ratios

CH:MEDX's free cash flow for Q4 2024 was CHF0.33. For the 2024 fiscal year, CH:MEDX's free cash flow was decreased by CHF and operating cash flow was CHF>-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.80 1.73 1.80 2.89 1.15
Quick Ratio
1.47 1.23 1.47 2.22 0.68
Cash Ratio
1.16 0.73 1.16 1.79 0.11
Solvency Ratio
0.10 0.10 0.10 0.22 0.11
Operating Cash Flow Ratio
0.18 0.31 0.18 0.74 0.38
Short-Term Operating Cash Flow Coverage
0.31 1.78 0.31 5.36 0.96
Net Current Asset Value
CHF -112.10MCHF -224.30MCHF -112.10MCHF -100.80MCHF -302.00M
Leverage Ratios
Debt-to-Assets Ratio
0.43 0.35 0.43 0.33 0.42
Debt-to-Equity Ratio
0.94 0.75 0.94 0.60 1.00
Debt-to-Capital Ratio
0.48 0.43 0.48 0.38 0.50
Long-Term Debt-to-Capital Ratio
0.33 0.35 0.33 0.31 0.42
Financial Leverage Ratio
2.19 2.16 2.19 1.83 2.37
Debt Service Coverage Ratio
0.42 1.66 0.42 4.23 0.99
Interest Coverage Ratio
3.02 1.58 3.02 7.40 2.35
Debt to Market Cap
0.56 0.36 0.56 0.14 0.16
Interest Debt Per Share
11.72 8.80 11.72 8.00 8.24
Net Debt to EBITDA
2.34 3.07 2.34 1.00 5.21
Profitability Margins
Gross Profit Margin
36.76%32.41%36.76%39.62%34.47%
EBIT Margin
3.92%2.67%3.92%13.05%5.21%
EBITDA Margin
14.32%14.67%14.32%24.19%17.34%
Operating Profit Margin
4.11%3.29%4.11%13.10%5.15%
Pretax Profit Margin
2.56%0.60%2.56%11.22%2.99%
Net Profit Margin
2.43%0.06%2.43%9.62%2.73%
Continuous Operations Profit Margin
2.43%0.14%2.43%9.62%2.76%
Net Income Per EBT
95.08%10.34%95.08%85.77%91.43%
EBT Per EBIT
62.24%18.13%62.24%85.64%58.01%
Return on Assets (ROA)
1.05%0.03%1.05%4.52%1.22%
Return on Equity (ROE)
2.30%0.06%2.30%8.24%2.88%
Return on Capital Employed (ROCE)
2.35%1.93%2.35%6.99%2.76%
Return on Invested Capital (ROIC)
1.87%0.44%1.87%5.83%2.34%
Return on Tangible Assets
1.59%0.05%1.59%7.58%2.61%
Earnings Yield
1.61%0.04%1.61%2.37%0.53%
Efficiency Ratios
Receivables Turnover
7.87 8.38 7.87 16.05 0.00
Payables Turnover
6.36 6.66 6.36 6.72 7.72
Inventory Turnover
3.29 3.72 3.29 3.49 3.65
Fixed Asset Turnover
2.08 1.89 2.08 1.99 1.69
Asset Turnover
0.43 0.48 0.43 0.47 0.44
Working Capital Turnover Ratio
2.17 2.80 2.17 3.77 6.96
Cash Conversion Cycle
100.08 86.86 100.08 73.12 52.64
Days of Sales Outstanding
46.36 43.58 46.36 22.75 0.00
Days of Inventory Outstanding
111.06 98.10 111.06 104.70 99.89
Days of Payables Outstanding
57.35 54.82 57.35 54.33 47.25
Operating Cycle
157.42 141.68 157.42 127.45 99.89
Cash Flow Ratios
Operating Cash Flow Per Share
1.16 1.37 1.16 2.12 1.23
Free Cash Flow Per Share
0.22 0.08 0.22 1.35 0.18
CapEx Per Share
0.94 1.29 0.94 0.78 1.04
Free Cash Flow to Operating Cash Flow
0.19 0.06 0.19 0.63 0.15
Dividend Paid and CapEx Coverage Ratio
0.89 0.83 0.89 1.19 0.53
Capital Expenditure Coverage Ratio
1.23 1.06 1.23 2.74 1.17
Operating Cash Flow Coverage Ratio
0.10 0.16 0.10 0.27 0.15
Operating Cash Flow to Sales Ratio
0.10 0.12 0.10 0.19 0.14
Free Cash Flow Yield
1.25%0.41%1.25%2.98%0.41%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
62.14 2.59K 62.14 42.20 189.12
Price-to-Sales (P/S) Ratio
1.51 1.60 1.51 4.06 5.17
Price-to-Book (P/B) Ratio
1.43 1.67 1.43 3.48 5.45
Price-to-Free Cash Flow (P/FCF) Ratio
80.10 242.66 80.10 33.51 242.07
Price-to-Operating Cash Flow Ratio
15.14 13.84 15.14 21.27 35.88
Price-to-Earnings Growth (PEG) Ratio
-0.84 -26.58 -0.84 0.12 -3.04
Price-to-Fair Value
1.43 1.67 1.43 3.48 5.45
Enterprise Value Multiple
12.90 13.94 12.90 17.79 35.03
Enterprise Value
880.86M 995.60M 880.86M 1.97B 2.13B
EV to EBITDA
12.90 13.94 12.90 17.79 35.03
EV to Sales
1.85 2.05 1.85 4.30 6.07
EV to Free Cash Flow
97.87 311.13 97.87 35.52 284.41
EV to Operating Cash Flow
18.51 17.75 18.51 22.54 42.16
Tangible Book Value Per Share
3.17 1.94 3.17 3.41 -2.14
Shareholders’ Equity Per Share
12.32 11.39 12.32 12.99 8.08
Tax and Other Ratios
Effective Tax Rate
0.05 0.76 0.05 0.14 0.08
Revenue Per Share
11.65 11.91 11.65 11.12 8.51
Net Income Per Share
0.28 <0.01 0.28 1.07 0.23
Tax Burden
0.95 0.10 0.95 0.86 0.91
Interest Burden
0.65 0.22 0.65 0.86 0.57
Research & Development to Revenue
0.05 0.05 0.05 0.05 0.06
SG&A to Revenue
0.22 0.24 0.22 0.21 0.23
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
4.10 80.14 4.10 1.98 5.27
Currency in CHF
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis